期刊文献+

丙泊酚复合芬太尼用于无痛胃镜对血流动力学影响 被引量:12

下载PDF
导出
摘要 目的:观察丙泊酚复合芬太尼在无痛胃镜检查中对患者血流动力学影响及相关并发症。方法:选择250例行无痛胃镜检查的患者采用丙泊酚复合芬太尼静脉麻醉,观察术中血压、心率、血氧饱和度变化及恶心、呕吐、躁动、呛咳等相关不良反应。结果:给药后血压明显低于给药前(P<0.01),心率在开始给药后5min到检查结束均低于给药前(P<0.01)。低血压发生率为33.6%,心动过缓为17.2%,呛咳为8.8%、躁动为19.6%。结论:丙泊酚复合芬太尼用于无痛胃镜检查中需严密监测循环及呼吸功能的变化,以确保患者安全。
作者 荣恒 何文政
出处 《广西医科大学学报》 CAS 2014年第1期143-144,共2页 Journal of Guangxi Medical University
  • 相关文献

参考文献8

  • 1Boillot A, Laurant P, Berthelot A, et al. Effects of propofol on vascular reactivity in isolated aortae from normotensive and spontaneously hypertensive rats[J]. Br J Anaesth,1999,83(4) :622-629.
  • 2Cheng TH, Chen JJ, Chen CH, et al. Effects ofpropofol on cyclic strain-induced endothelin-1 expression in hu- man umbilical vein endothelial cells[J]. Anesthesiolo gy,2009,110(1):74 -80.
  • 3Krassioukov AV, Gelb AW, Weaver LC. Action of propofoI on central sympathetic mechanisms controlling blood pressure[J]. Can J Anaesth, 1993,40 (8) : 761- 769.
  • 4Votta-Velis EG, Minshall RD, Visintine DJ, et al. Propofol attenuates endotoxin-induced endothelial cell injury, angiotensin-converting enzyme shedding, and lung edema[J]. Anesth Analg, 2007,105(5):1 363- 1 370.
  • 5Yang CY,Wong CS,Yu CC,et al. Propofol inhibits car- diac L type calcium current in guinea pig ventricular myocytes[J]. Anesthesiology, 1996,84(3) : 626-635.
  • 6Robinson BJ, Ebert TJ, O'Brien TJ, et al. Mechanisms where by propofol mediates peripheral vasodilation in humans. Sympathoinhibition or direct vascular relaxa- tion[J]. Anesthesiology, 1997,86(1) :64-72.
  • 7王祥瑞,孙大金,杭燕南,许灿然,金正均.异丙酚的血药浓度与临床效应的关系[J].中华麻醉学杂志,1996,16(7):292-294. 被引量:67
  • 8王琪,张立生,徐贯杰,么孝恩,韩艾伦.芬太尼在麻醉诱导期对丙泊酚药代动力学的影响[J].临床麻醉学杂志,2003,19(9):555-556. 被引量:66

二级参考文献10

  • 1Ben-Shlomo I, Finger J, Bar-Av E, et al. Propofol and fentanyl act additively for induction of anaesthesia. Anaesthsia, 1993,48:111-113.
  • 2Vuyk J, Lira T, Engbers FH, et al. Pharmacodynamics of alfentanil as a supplement to propofol or nitrous oxide for lower abdominal surgery in female patients. Anaesthesiology, 1993,78 : 1036-1045.
  • 3Vree TB, Baars AM, de Grood PM. High performance liquid chromatographic determination and preliminary pharmacokinetics of propofol and its metabolites in human plasma and urine. J Chromatogr, 1987,417 : 458-464.
  • 4Kirkpatrick T, Cockshott ID, Douglas EJ, et al. Pharmacokineties of propofol (Diprivan)in elderly patients.British J Anaesthsia, 1988,60 : 146-150.
  • 5Vuyk J. Pharmacokinetic and pharmacodynamic interactions between opioids and propofol. J Clin Anesth, 1997,9(Suppl 6) :23-26.
  • 6Murat I, Billard V, Vernois J, et al. Pharmacokinetics of propofol after a single dose in children aged 1-3 years with minor burns. Comparison of three data analysis approaches. Anaesthesiology, 1996,84 : 526-532.
  • 7Schutthr J, Ihmsen H. Population pharmacokinetics of propofol., a multicenter study. Anaesthesiology, 2000,92 :727-738.
  • 8Schnider TW, Minto CF, Sharer SL, et al. The influence of age on propofol pharmacodynamics. Anaesthesiology,1999,90 : 1502-1516.
  • 9王祥瑞,实用麻醉学杂志,1995年,8卷,1页
  • 10杨威,郑方,李文志,周少鹏,李德辉,李继庆.芬太尼对异丙酚静脉麻醉药代动力学和药效学的影响[J].中华麻醉学杂志,1999,19(12):708-710. 被引量:52

共引文献131

同被引文献80

引证文献12

二级引证文献95

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部